Career history of W. Rowlands
Former positions of W. Rowlands
| Companies | Position | Start | End |
|---|---|---|---|
| A-LABS CAPITAL II CORP. | Director/Board Member | 2018-09-04 | 2023-06-30 |
| Independent Dir/Board Member | 2018-09-04 | 2023-06-30 | |
| XORTX THERAPEUTICS INC. | Director/Board Member | 2018-01-08 | 2018-05-07 |
| Chairman | 2018-05-07 | 2021-12-19 | |
| Independent Dir/Board Member | 2018-01-08 | 2021-12-19 | |
| Public Communications Contact | 2018-01-08 | 2021-12-19 | |
| TALISKER RESOURCES LTD. | Director/Board Member | 2018-03-14 | 2018-09-25 |
| Chief Executive Officer | 2006-03-31 | 2018-03-14 | |
| Chairman | 2012-06-27 | 2018-03-14 | |
| President | 2006-03-31 | 2014-07-31 | |
| APTOSE BIOSCIENCES INC. | Public Communications Contact | 2002-12-31 | 2004-12-31 |
| Dominick & Dominick Securities, Inc. | Director/Board Member | 1998-12-31 | 2002-12-31 |
| Corporate Officer/Principal | 1998-12-31 | 2002-12-31 | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Director/Board Member | 2014-10-31 | - |
Statistics
International
| Canada | 7 |
Operational
| Director/Board Member | 5 |
| Public Communications Contact | 2 |
| Chairman | 2 |
Sectoral
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| TALISKER RESOURCES LTD. | Non-Energy Minerals |
| XORTX THERAPEUTICS INC. | Health Technology |
| A-LABS CAPITAL II CORP. | Finance |
| Private companies | 2 |
|---|---|
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
| Dominick & Dominick Securities, Inc. |
- Stock Market
- Insiders
- W. Rowlands
- Experience
